Cargando…
Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward
A licensed anthrax vaccine has been available for pre-exposure prophylaxis in the United States since 1970, and it was approved for use as a post-exposure prophylaxis, in combination with antibiotic treatment, in 2015. A variety of other vaccines are available in other nations, approved under variou...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285291/ https://www.ncbi.nlm.nih.gov/pubmed/32365729 http://dx.doi.org/10.3390/microorganisms8050651 |